Reptiles, Toxicology, and the Future of Cell and Gene Therapy | Dr. Andy Vick
BioTalk Unzipped15 Jul 2024

Reptiles, Toxicology, and the Future of Cell and Gene Therapy | Dr. Andy Vick

What can reptile venom teach us about medicine, and what separates merely good scientific work from truly great work?

Dr. Andy Vick returns to BioTalk Unzipped for a conversation that moves from drug development and toxicology into reptiles, academia, gene therapy, professional development, and the extraordinary possibilities opening up across modern medicine.

Andy shares the discoveries and industry changes that have surprised him over the course of his career, including how dramatically some areas of cancer treatment have changed.

Then science meets one of his personal passions: reptiles. Andy describes his rare reptile collection and his work educating future toxicologists about venom and its potential pharmaceutical applications.

The discussion moves into Andy’s role as an adjunct professor at The Ohio State University and his work connecting academic research, students, and industry.

In New News, Gregory, Chad, and Andy discuss gene therapy used to restore hearing in children with mutations affecting otoferlin. The story opens a broader discussion about the extraordinary therapeutic potential of cell and gene therapy as well as the safety and tolerability questions researchers still need to answer.

Andy closes by discussing the role organizations such as AAPS play in scientific collaboration, networking, mentorship, and professional growth.

Chapters

00:21 - Surprises throughout Dr. Vick’s career

02:24 - The cyclical nature of technology

03:30 - Exploring the pharmaceutical potential of venom

05:35 - Improvements in cancer and other diseases over the past 30 years

10:13 - Educating future toxicologists about reptiles and pharmaceuticals

15:45 - Andrew Vick’s role as an adjunct professor at The Ohio State University

21:21 - New News: Restoring hearing in children through gene therapy

27:27 - The impact of professional organizations such as AAPS

Selected quotes“It’s probably a good 10 years from the glimmer in a biochemist’s eyes to on the market.”“There’s a logarithmic difference between great and good.”“Just use your imagination on a way to tackle a disease and then find a way.”“Cell and gene therapy opens the door to a whole different category of opportunities.”Connect with Dr. Andy Vick

Dr. Andy Vick

https://www.linkedin.com/in/andy-vick-4467189/

Attralus Therapeutics

https://www.attralus.com/

Connect with the hosts

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

New News

Regeneron gene therapy restores hearing in two children:

https://www.fiercebiotech.com/biotech/little-protein-factory-could-regeneron-gene-therapy-restores-hearing-2-kids

Image credit

Pharmacognosy:

https://pharmacognosy-phytochemistry-natural-products.pharmaceuticalconferences.com/events-list/industrial-pharmacognosy

Keywords

toxicology, reptiles, venom, drug discovery, drug development, gene therapy, hearing loss, academia, AAPS, cell and gene therapy, biotechnology

#biotechnology #toxicology #genetherapy #hearingloss #AAPS #science

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
rss-skravla-gar
lederpodden
rss-pa-konto
utbytte
pengepodden-2
livet-pa-veien-med-jan-erik-larssen
morgenkaffen-med-finansavisen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
liberal-halvtime
rss-markedspuls-2
pengesnakk
rss-politisk-preik
okonomiamatorene